SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$98.33
Tradestie Score
52
Market Cap
$994.20M
Analyst Upside
+7.6%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$51.77
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$80.09
|
$10.22B | - | 56 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$467.32
|
$10.01B | - | 52 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.09
|
$9.33B | 102.9 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$114.49
|
$8.88B | 262.9 | 59 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$82.54
|
$8.77B | 29.2 | 59 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$187.53
|
$8.57B | - | 60 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$15.67
|
$8.53B | - | 45 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$252.86
|
$8.30B | 2583.8 | 60 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
More SYRE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry